MWNA
HRTX icon

Marshall Wace North America’s Heron Therapeutics HRTX Stock Holding History

Marshall Wace North America’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$282K Buy
+26,362
New +$321K ﹤0.01% 1263
2019
Q2 		– Sell
-4,522
Closed -$111K – 1338
2019
Q1 		$111K Sell
4,522
-6,815
-60% -$178K ﹤0.01% 1097
2018
Q4 		$294K Buy
+11,337
New +$312K ﹤0.01% 892
2018
Q3 		– Sell
-156,298
Closed -$6.07M – 1109
2018
Q2 		$6.07M Buy
+156,298
New +$4.98M 0.03% 468

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return